These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13746960)

  • 21. Comparative study on plant latex proteases and their involvement in hemostasis: a special emphasis on clot inducing and dissolving properties.
    Rajesh R; Shivaprasad HV; Gowda CD; Nataraju A; Dhananjaya BL; Vishwanath BS
    Planta Med; 2007 Aug; 73(10):1061-7. PubMed ID: 17691056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrochemical processing of fibrinogen modified-graphite surfaces: effect on plasmin generation from adsorbed plasminogen.
    Alfonsi-Hourdin S; Longchamp S; Gallet O; Nigretto JM
    Biomaterials; 2006 Jan; 27(1):52-60. PubMed ID: 16029886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrinolysin; its practical use in the study of the action of proteolytic enzymes and their inhibitors].
    SOULIER JP
    Sem Hop; 1948 Aug; 24(62):2021-6. PubMed ID: 18883661
    [No Abstract]   [Full Text] [Related]  

  • 24. Properties of leucocytic protease.
    Ohlsson K
    Clin Chim Acta; 1971 May; 32(3):399-405. PubMed ID: 4255456
    [No Abstract]   [Full Text] [Related]  

  • 25. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
    Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma.
    CLIFFTON EE; CANNAMELA D
    J Appl Physiol; 1953 Jul; 6(1):42-50. PubMed ID: 13084519
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinogenolytic dysfibrinogenemias.
    Fletcher AP
    Fed Proc; 1965; 24(4):822-6. PubMed ID: 4220569
    [No Abstract]   [Full Text] [Related]  

  • 28. Proteolytic capacity in human plasma. II. Genetics, and clinical study.
    Jacobsen CD
    Scand J Clin Lab Invest; 1968; 21(3):227-37. PubMed ID: 4236913
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A family with low proteolytic capacity in plasma, probably related to a low plasminogen content.
    Jacobsen CD
    Scand J Clin Lab Invest; 1966; 18(3):359-60. PubMed ID: 5919200
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood fibrinogen and fibrinolytic and fibrinogenolytic activity of plasma in Hodgkin's granuloma].
    ZARDI O
    Prog Med (Napoli); 1954 May; 10(10):294-7. PubMed ID: 13186012
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on a proteolytic enzyme system of the blood. II. Fibrinolysokinase activators for profibrinolysin.
    LEWIS JH; FERGUSON JH; HOWE AC; ROGERS J
    J Clin Invest; 1950 Aug; 29(8):1059-68. PubMed ID: 15436875
    [No Abstract]   [Full Text] [Related]  

  • 33. [The dependence of the complement system and its fraction on the activity of proteolytic enzymes].
    Pietruska Z; Stasiewicz A; Drozd J
    Pol Tyg Lek; 1973 Jul; 28(30):1137-41. PubMed ID: 4732708
    [No Abstract]   [Full Text] [Related]  

  • 34. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-acting fibrinolytic enzymes in shark cartilage extract: potential therapeutic role in vascular disorders.
    Ratel D; Glazier G; Provençal M; Boivin D; Beaulieu E; Gingras D; Béliveau R
    Thromb Res; 2005; 115(1-2):143-52. PubMed ID: 15567466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative immunochemical characterization of products of plasmin and leukocyte protease cleavage of human fibrinogen.
    Plow EF; Edgington TS
    Thromb Res; 1978 Apr; 12(4):653-65. PubMed ID: 149393
    [No Abstract]   [Full Text] [Related]  

  • 37. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the proteolytic activity of saliva, serum and urine.
    Pawilowska-Michalik H; Halawa B; Potoczek S
    Pol Med J; 1969; 8(3):699-701. PubMed ID: 5807577
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activation of a proteolytic enzyme in blood by animal tissue.
    ASTRUP T
    Biochem J; 1951 Nov; 50(1):5-11. PubMed ID: 14904365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.